Article | February 28, 2017

Why Your R&D Externalization Strategy Needs A Laboratory Informatics Strategy

Source: Astrix Technology Group
Why Your R&D Externalization Strategy Needs A Laboratory Informatics Strategy

For the last several years, a rebounding global economy combined with a growing demand for advanced therapeutics has resulted in robust pipelines and the highest FDA approval rates seen in decades.  As a result of heighted R&D activity, we are seeing more rapid commercialization of innovative drugs for patients. Congress has also recently introduced a new bill called the 21st Century Cures Act designed to further speed up approvals and remove red tape.  Medical devices are following a similar suit.  According to a Food and Drug Administration2015 performance report, the approval rate for high-risk medical devices jumped to 98 percent in 2015, a 12 percent increase from the previous year and an almost 30 percent approval increase from 2012.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Laboratory Network? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: